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Prostate cancer is the most common type of cancer and
the second leading cause of death due to malignancy
among men in Western populations after skin cancer
[1]. About 30% of patients with prostate cancer have
regional or distant metastasis at the time of diagnosis
[2]. Bone metastases of prostatic cancer are the most
common form of distant spreading [1,2]. The most
frequent sites of bone metastases are the pelvis and
vertebrae [1]. Despite the frequency of bone metasta-
sis in prostatic carcinoma, oculo-orbital metastases
are considered extremely rare [3]. In this report, we
present a case of prostatic cancer metastasizing to the
left orbital cavity.
CASE PRESENTATION
A 73-year-old man was referred to our clinic with a 
4-month history of left periorbital swelling and pain.
During the last 2 weeks, the symptoms had been wors-
ening. A moderate degree of left-sided proptosis and
ipsilateral visual loss were detected in ophthalmologic
examination. The patient had a history of recurrent
urinary tract infection and lower urinary tract symp-
toms such as dysuria, frequency and pollakuria. Uri-
nalysis revealed microscopic hematuria and 2–3 white
blood cells per high power field. Increased serum
alkaline phosphatase (ALP) level and anemia were
also found in laboratory examination. Complete phys-
ical examination was unremarkable except for the dig-
ital rectal examination. Firm and nodular prostatic
tissue was palpated on rectal examination. Serum
prostatic specific antigen (PSA) level was 873 ng/mL.
Magnetic resonance imaging (MRI) of the cra-
nium showed retro-orbital mass measuring 4 × 3 cm 
(Figure 1). Computed tomography (CT) confirmed
these findings. There were no other visceral metas-
tases at presentation. Bone scanning showed multiple
osseous metastases in pelvic bones, vertebrae and
humerus. Histopathologic examination of the fine
needle aspiration biopsy (FNAB) from the orbital mass
revealed cellular smears, in which there were atypical
epithelial cells with large regular nuclei and promi-
nent nucleoli. These cells formed large clusters and aci-
nar structures (Figure 2). In addition, granular material
due to fragmentation of cell cytoplasm was present
in the background. These findings indicated a malig-
nant epithelial tumor metastasis that may have arose
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secondary to prostate carcinoma. After this histo-
pathologic diagnosis, tru-cut biopsy of the prostate
gland was performed. Biopsy result was reported as
prostatic adenocarcinoma with Gleason grade 4 + 4
(Figure 3). With a diagnosis of advanced disease, the
patient received total androgen blockade with luteiniz-
ing hormone releasing hormone analog and flutamide.
After 2 months of hormonotherapy, the left-sided
proptosis subsided and a significant improvement 
in vision was observed as well. The PSA values were
434 ng/mL and 293 ng/mL in the 3rd and 7th months,
respectively. Although radiotherapy was recommend-
ed, the patient refused this treatment modality. The
patient died due to brain metastasis 12 months after
diagnosis.
DISCUSSION
Orbital metastasis of a neoplasm is an uncommon
entity in adults and it represents only 2–9% of orbital
tumors [1,3]. Epithelial and non-epithelial metastatic
tumors can be seen in orbital localization. Non-
epithelial metastatic tumors that occur in the orbital
cavity are neuroblastomas, melanomas and sarcomas
[4]. The most common epithelial tumors are adeno-
carcinomas originating from the breast, lung, prostate,
stomach, thyroid, and kidney [1,4]. Prostate cancer is
an important health problem in the aging male popula-
tion. The most common sites of metastasis beyond the
periprostatic region are the pelvic nodes and the pelvic,
lumbosacral spine, and long bones [4]. Soft-tissue
metastases of prostate cancer are very rare. The first
case of metastatic prostatic carcinoma to the eye was
reported in 1872 [5], and in 1903 Greenwood and
Southard reported a case of prostate carcinoma metas-
tasis to the choroid [6]. Since then, only a few cases of
orbital metastasis from prostate cancer have been
reported in the literature. Recent studies have indicated
prostate cancer as the 3rd most commonly identified
source of orbital metastasis [4,7]. In 1986, Perez
Moreiras found a case secondary to prostate cancer out
of 23 cases with metastasis to the orbit [8]. In a series of
227 cases with carcinomatous metastasis to the eye and
orbit, only three patients (1.3%) had an associating pri-
mary lesion in the prostate gland [9]. The largest series
of oculo-orbital metastasis from prostate cancer includ-
ing seven patients was published by De Potter et al [10].
L
Figure 1. Metastatic tumoral mass (arrow) in the left retro-orbital
region is seen on magnetic resonance imaging.
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Figure 2. (A) Aspiration smear shows atypical epithelial cells with large nuclei and prominent nucleoli (arrowheads) (May-
Grünwald-Giemsa [MGG], 10×). (B) An acinar structure (arrows) formed by atypical epithelial cells was noted in the smear (MGG, 40×).
There are two routes of metastasis to the orbital
region. The first one is through lung metastases, where
tumor emboli pass via pulmonary circulation into the
choroid arteries and subsequently into the ophthalmic
artery. Secondly, prostatic or vertebral lesions may
seed into Batson’s plexus and reach the cranial venous
sinuses traveling up to the ophthalmic and vertex
veins [4]. The usual presenting symptoms are visual
loss, ptosis, ocular pain, osteoblastic lesions of the
orbital wall and diplopia due to the orbital involve-
ment. Physical examination showed ptosis and a pal-
pable mass [3,4,7]. Review of the literature indicates
that about two-thirds of the cases with prostate cancer
metastasis were diagnosed after the development of
ocular symptoms and those metastases could mimic
a variety of other conditions such as primary orbital
tumor, secondary extension from adjacent primary
neoplasms, lymphomas, meningiomas, and arteriove-
nous malformations [3,7]. Radiologic studies can 
also help in the diagnosis of metastatic tumors. The
most common finding on CT is a well-defined, con-
trast enhancing, intraconal mass and osteoblastic
lesions. The diagnosis of orbital metastasis of prostate
cancer is achieved by cytologic examination of fine
needle aspiration material as in this case, but ocular
enucleation or evisceration of the orbit [3,11]. Nuclear
crowding, microglandular groups, nuclear and nucle-
olar enlargement, variable pleomorphism are fre-
quently seen cytologic findings [3,10,11,14]. In this
case, FNAB showed cellular smears, nuclear crowd-
ing, nuclear–nucleolar enlargement, acinar structures,
fragile vacuolated cytoplasm and mild–moderate
pleomorphism. These cytologic findings support the
diagnosis of a malignant epithelial tumor. Upon these
histologic findings, examination of the prostate gland
should be done as the first step for male patients. As
long as the FNAB indicates the lesion to be malignant
epithelial tumor, especially of prostatic origin, the
prostate gland of the patient should be evaluated
subsequently. The performed tru-cut biopsy revealed
prostatic carcinoma, Gleason score 4 + 4.
Treatment modalities for metastatic orbital tumors
include chemotherapy, hormonal therapy, radiation
therapy and combined therapy [1,3,11–14]. Dieckert
and Berger reported a patient with choroidal metas-
tasis who responded to hormonal therapy alone [15].
De Potter et al reported complete ocular response after
hormonal therapy combined with radiotherapy to uvea
as seen in their patients [10]. Enucleation of the mass
is a rarely used option for cases of complete blindness
or intractable pain. Following anti-androgenic hor-
monal therapy, ptosis and pain disappeared in this
case. After radiation therapy, marked relief of symp-
toms may be seen in more than 80% of patients [1,3].
We offered radiotherapy to the orbital region, but the
patient refused this treatment modality. The progno-
sis for patients with metastatic disease to the orbital
region is poor. Various studies reported an overall
median survival rate of 7.4–24.5 months [1,3,7–13]. 
It was 12 months in this case.
In conclusion, metastatic orbital tumor secondary
to prostate cancer should be considered in patients
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Figure 3. (A) Gleason score 4+4 infiltrative malignant tumoral growth which consists of neoplastic microacinar structures and single
atypical epithelial cells in tru-cut biopsy section of prostate gland (hematoxylin and eosin, 10×). (B) Higher magnification shows atypical
neoplastic microacinar structures made by epithelial cells and pleomorphic, hyperchromatic nuclei with prominent nucleoli (hematoxylin
and eosin, 40×).
who have elevated serum PSA level and abnormal
digital rectal examination findings in addition to ptosis
and loss of vision complaints. The prognosis of orbital
metastasis due to prostate cancer seems to be better
than the other oculo-orbital metastatic cancers. In
addition, it should be appreciated that a finding of
very high serum PSA levels is an indicator of a poorer
outcome.
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